{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:41:03Z","timestamp":1774262463019,"version":"3.50.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,7,25]],"date-time":"2015-07-25T00:00:00Z","timestamp":1437782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s11892-015-0634-1","type":"journal-article","created":{"date-parts":[[2015,7,24]],"date-time":"2015-07-24T05:56:38Z","timestamp":1437717398000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes Pathogenesis"],"prefix":"10.1007","volume":"15","author":[{"given":"Daniel","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Kirsop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. H. Wilson","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,25]]},"reference":[{"issue":"5728","key":"634_CR1","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","volume":"308","author":"PB Eckburg","year":"2005","unstructured":"Eckburg PB et al. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635\u20138.","journal-title":"Science"},{"issue":"8","key":"634_CR2","doi-asserted-by":"crossref","first-page":"e6669","DOI":"10.1371\/journal.pone.0006669","volume":"4","author":"MJ Claesson","year":"2009","unstructured":"Claesson MJ et al. Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine. PLoS One. 2009;4(8):e6669.","journal-title":"PLoS One"},{"issue":"7164","key":"634_CR3","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nature06244","volume":"449","author":"PJ Turnbaugh","year":"2007","unstructured":"Turnbaugh PJ et al. The human microbiome project. Nature. 2007;449(7164):804\u201310.","journal-title":"Nature"},{"issue":"44","key":"634_CR4","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","volume":"101","author":"F Backhed","year":"2004","unstructured":"Backhed F et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101(44):15718\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"634_CR5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1073\/pnas.0605374104","volume":"104","author":"F Backhed","year":"2007","unstructured":"Backhed F et al. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A. 2007;104(3):979\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7122","key":"634_CR6","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh PJ et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027\u201331.","journal-title":"Nature"},{"issue":"12","key":"634_CR7","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1007\/s00125-011-2329-8","volume":"54","author":"J Amar","year":"2011","unstructured":"Amar J et al. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia. 2011;54(12):3055\u201361.","journal-title":"Diabetologia"},{"issue":"11","key":"634_CR8","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/ijo.2011.256","volume":"36","author":"JM Moreno-Navarrete","year":"2012","unstructured":"Moreno-Navarrete JM et al. Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance. Int J Obes (Lond). 2012;36(11):1442\u20139.","journal-title":"Int J Obes (Lond)"},{"issue":"7","key":"634_CR9","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"PD Cani","year":"2007","unstructured":"Cani PD et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56(7):1761\u201372.","journal-title":"Diabetes"},{"issue":"3","key":"634_CR10","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1152\/physrev.2001.81.3.1031","volume":"81","author":"DL Topping","year":"2001","unstructured":"Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001;81(3):1031\u201364.","journal-title":"Physiol Rev"},{"issue":"10","key":"634_CR11","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1093\/ajcn\/32.10.2094","volume":"32","author":"JH Cummings","year":"1979","unstructured":"Cummings JH et al. The effect of meat protein and dietary fiber on colonic function and metabolism. II. Bacterial metabolites in feces and urine. Am J Clin Nutr. 1979;32(10):2094\u2013101.","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"634_CR12","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2174\/1389200211314090006","volume":"14","author":"P Goncalves","year":"2013","unstructured":"Goncalves P, Martel F. Butyrate and colorectal cancer: the role of butyrate transport. Curr Drug Metab. 2013;14(9):994\u20131008.","journal-title":"Curr Drug Metab"},{"issue":"6","key":"634_CR13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1365-2036.1998.00337.x","volume":"12","author":"SI Cook","year":"1998","unstructured":"Cook SI, Sellin JH. Review article: short chain fatty acids in health and disease. Aliment Pharmacol Ther. 1998;12(6):499\u2013507.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"634_CR14","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/jms.181","volume":"36","author":"E Pouteau","year":"2001","unstructured":"Pouteau E et al. Acetate, propionate and butyrate in plasma: determination of the concentration and isotopic enrichment by gas chromatography\/mass spectrometry with positive chemical ionization. J Mass Spectrom. 2001;36(7):798\u2013805.","journal-title":"J Mass Spectrom"},{"issue":"3","key":"634_CR15","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/ajcn\/37.3.376","volume":"37","author":"TK Ray","year":"1983","unstructured":"Ray TK et al. Long-term effects of dietary fiber on glucose tolerance and gastric emptying in noninsulin-dependent diabetic patients. Am J Clin Nutr. 1983;37(3):376\u201381.","journal-title":"Am J Clin Nutr"},{"issue":"15","key":"634_CR16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJM197710132971506","volume":"297","author":"AI Mendeloff","year":"1977","unstructured":"Mendeloff AI. Dietary fiber and human health. N Engl J Med. 1977;297(15):811\u20134.","journal-title":"N Engl J Med"},{"issue":"5","key":"634_CR17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00125-003-1081-0","volume":"46","author":"MD Robertson","year":"2003","unstructured":"Robertson MD et al. Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia. 2003;46(5):659\u201365.","journal-title":"Diabetologia"},{"key":"634_CR18","doi-asserted-by":"crossref","unstructured":"Karlsson FH et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99\u2013103. These two studies (18,19) provide the first metagenomic evidence of differing profiles between diabetes and normal individuals and suggest the potential to predict development of disease from metagenomic sequences.","DOI":"10.1038\/nature12198"},{"issue":"7418","key":"634_CR19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","volume":"490","author":"J Qin","year":"2012","unstructured":"Qin J et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55\u201360. These two studies (18,19) provide the first metagenomic evidence of differing profiles between diabetes and normal individuals and suggest the potential to predict development of disease from metagenomic sequences.","journal-title":"Nature"},{"issue":"28","key":"634_CR20","doi-asserted-by":"crossref","first-page":"25481","DOI":"10.1074\/jbc.M301403200","volume":"278","author":"E Poul Le","year":"2003","unstructured":"Le Poul E et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem. 2003;278(28):25481\u20139.","journal-title":"J Biol Chem"},{"issue":"13","key":"634_CR21","doi-asserted-by":"crossref","first-page":"11312","DOI":"10.1074\/jbc.M211609200","volume":"278","author":"AJ Brown","year":"2003","unstructured":"Brown AJ et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278(13):11312\u20139.","journal-title":"J Biol Chem"},{"key":"634_CR22","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/ncomms2852","volume":"4","author":"I Kimura","year":"2013","unstructured":"Kimura I et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun. 2013;4:1829.","journal-title":"Nat Commun"},{"issue":"43","key":"634_CR23","doi-asserted-by":"crossref","first-page":"16767","DOI":"10.1073\/pnas.0808567105","volume":"105","author":"BS Samuel","year":"2008","unstructured":"Samuel BS et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A. 2008;105(43):16767\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"634_CR24","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/db11-1019","volume":"61","author":"G Tolhurst","year":"2012","unstructured":"Tolhurst G et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61(2):364\u201371.","journal-title":"Diabetes"},{"issue":"4","key":"634_CR25","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","volume":"87","author":"JJ Holst","year":"2007","unstructured":"Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409\u201339.","journal-title":"Physiol Rev"},{"issue":"3","key":"634_CR26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1017\/S0007114509991863","volume":"103","author":"KR Freeland","year":"2010","unstructured":"Freeland KR, Wolever TM. Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alpha. Br J Nutr. 2010;103(3):460\u20136.","journal-title":"Br J Nutr"},{"issue":"4","key":"634_CR27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","volume":"143","author":"A Vrieze","year":"2012","unstructured":"Vrieze A et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143(4):913\u20136. e7.","journal-title":"Gastroenterology"},{"issue":"5","key":"634_CR28","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/ajcn\/87.5.1219","volume":"87","author":"J Amar","year":"2008","unstructured":"Amar J et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr. 2008;87(5):1219\u201323.","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"634_CR29","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","volume":"116","author":"H Shi","year":"2006","unstructured":"Shi H et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006;116(11):3015\u201325.","journal-title":"J Clin Invest"},{"issue":"15","key":"634_CR30","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1096\/fj.00-0359fje","volume":"14","author":"MD Saemann","year":"2000","unstructured":"Saemann MD et al. Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J. 2000;14(15):2380\u20132.","journal-title":"FASEB J"},{"issue":"4","key":"634_CR31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3920\/BM2010.0028","volume":"1","author":"H Roelofsen","year":"2010","unstructured":"Roelofsen H, Priebe MG, Vonk RJ. The interaction of short-chain fatty acids with adipose tissue: relevance for prevention of type 2 diabetes. Benefic Microbes. 2010;1(4):433\u20137.","journal-title":"Benefic Microbes"},{"issue":"9","key":"634_CR32","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3945\/jn.109.104638","volume":"139","author":"L Peng","year":"2009","unstructured":"Peng L et al. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr. 2009;139(9):1619\u201325.","journal-title":"J Nutr"},{"issue":"5","key":"634_CR33","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmet.2014.10.006","volume":"20","author":"RA Koeth","year":"2014","unstructured":"Koeth RA et al. gamma-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab. 2014;20(5):799\u2013812. This study and reference [47] provide novel insights into the metabolism of TMAO and its associations with various gut microbiome profiles.","journal-title":"Cell Metab"},{"issue":"10","key":"634_CR34","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1172\/JCI72331","volume":"124","author":"WH Tang","year":"2014","unstructured":"Tang WH, Hazen SL. The contributory role of gut microbiota in cardiovascular disease. J Clin Invest. 2014;124(10):4204\u201311.","journal-title":"J Clin Invest"},{"key":"634_CR35","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1074\/jbc.M114.618249","volume":"290","author":"JC Gregory","year":"2014","unstructured":"Gregory JC et al. Transmission of atherosclerosis susceptibility with gut microbial transplantation. J Biol Chem. 2014;290:5647\u201360.","journal-title":"J Biol Chem"},{"issue":"7341","key":"634_CR36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57\u201363. In this study, Wang et al. uses a metabolomic screen to identify TMAO as a novel gut microbiota-dependent metabolite that is a potential modifiable risk factor for cardiovascular disease.","journal-title":"Nature"},{"issue":"18","key":"634_CR37","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.jacc.2014.02.617","volume":"64","author":"WH Tang","year":"2014","unstructured":"Tang WH et al. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J Am Coll Cardiol. 2014;64(18):1908\u201314.","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"634_CR38","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","volume":"368","author":"WH Tang","year":"2013","unstructured":"Tang WH et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575\u201384. In this clinical study with over 4000 participants, the authors reconfirmed the gut microbiota dependence of TMAO in human subjects and found that serum TMAO levels predicted 3-year incident cardiovascular risk in a dose-dependent manner.","journal-title":"N Engl J Med"},{"key":"634_CR39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cardfail.2014.11.006","volume":"21","author":"WH Tang","year":"2014","unstructured":"Tang WH et al. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction and adverse clinical outcomes in chronic systolic heart failure. J Card Fail. 2014;21:91\u20136.","journal-title":"J Card Fail"},{"issue":"14","key":"634_CR40","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/eurheartj\/ehu002","volume":"35","author":"Z Wang","year":"2014","unstructured":"Wang Z et al. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. Eur Heart J. 2014;35(14):904\u201310.","journal-title":"Eur Heart J"},{"issue":"4","key":"634_CR41","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm.2307","volume":"17","author":"TJ Wang","year":"2011","unstructured":"Wang TJ et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17(4):448\u201353.","journal-title":"Nat Med"},{"issue":"12","key":"634_CR42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114969","volume":"9","author":"M Lever","year":"2014","unstructured":"Lever M et al. Betaine and trimethylamine-N-oxide as predictors of cardiovascular outcomes show different patterns in diabetes mellitus: an observational study. PLoS ONE. 2014;9(12), e114969.","journal-title":"PLoS ONE"},{"issue":"4","key":"634_CR43","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jbiosc.2014.03.001","volume":"118","author":"X Gao","year":"2014","unstructured":"Gao X et al. Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet. J Biosci Bioeng. 2014;118(4):476\u201381.","journal-title":"J Biosci Bioeng"},{"key":"634_CR44","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1038\/ncomms7498","volume":"6","author":"J Miao","year":"2015","unstructured":"Miao J et al. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis. Nat Commun. 2015;6:6498. This study shows that knockdown of FMO3 and subsequently TMAO levels can prevent the development of hyperglycemia, hyperlipidemia, and atherosclerosis in a diabetes mouse model.","journal-title":"Nat Commun"},{"issue":"1","key":"634_CR45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1194\/jlr.M051680","volume":"56","author":"DM Shih","year":"2015","unstructured":"Shih DM et al. Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis. J Lipid Res. 2015;56(1):22\u201337.","journal-title":"J Lipid Res"},{"issue":"3","key":"634_CR46","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","volume":"116","author":"WH Tang","year":"2015","unstructured":"Tang WH et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015;116(3):448\u201355.","journal-title":"Circ Res"},{"issue":"5","key":"634_CR47","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth RA et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576\u201385. See reference 33.","journal-title":"Nat Med"},{"issue":"11","key":"634_CR48","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1753-4887.2009.00246.x","volume":"67","author":"SH Zeisel","year":"2009","unstructured":"Zeisel SH, da Costa KA. Choline: an essential nutrient for public health. Nutr Rev. 2009;67(11):615\u201323.","journal-title":"Nutr Rev"},{"issue":"4","key":"634_CR49","first-page":"547","volume":"21","author":"DM Chu","year":"2012","unstructured":"Chu DM et al. Choline and betaine food sources and intakes in Taiwanese. Asia Pac J Clin Nutr. 2012;21(4):547\u201357.","journal-title":"Asia Pac J Clin Nutr"},{"issue":"6","key":"634_CR50","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1194\/jlr.R700019-JLR200","volume":"49","author":"Z Li","year":"2008","unstructured":"Li Z, Vance DE. Phosphatidylcholine and choline homeostasis. J Lipid Res. 2008;49(6):1187\u201394.","journal-title":"J Lipid Res"},{"issue":"9","key":"634_CR51","first-page":"714","volume":"63","author":"L Paoletti","year":"2011","unstructured":"Paoletti L et al. Role of phosphatidylcholine during neuronal differentiation. IUBMB Life. 2011;63(9):714\u201320.","journal-title":"IUBMB Life"},{"issue":"9","key":"634_CR52","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.clinbiochem.2010.03.009","volume":"43","author":"M Lever","year":"2010","unstructured":"Lever M, Slow S. The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. Clin Biochem. 2010;43(9):732\u201344.","journal-title":"Clin Biochem"},{"key":"634_CR53","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1475-2840-11-34","volume":"11","author":"M Lever","year":"2012","unstructured":"Lever M et al. Variability of plasma and urine betaine in diabetes mellitus and its relationship to methionine load test responses: an observational study. Cardiovasc Diabetol. 2012;11:34.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"634_CR54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037883","volume":"7","author":"M Lever","year":"2012","unstructured":"Lever M et al. Betaine and secondary events in an acute coronary syndrome cohort. PLoS One. 2012;7(5), e37883.","journal-title":"PLoS One"},{"issue":"Pt 5","key":"634_CR55","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1042\/BST0351175","volume":"35","author":"EP Wijekoon","year":"2007","unstructured":"Wijekoon EP, Brosnan ME, Brosnan JT. Homocysteine metabolism in diabetes. Biochem Soc Trans. 2007;35(Pt 5):1175\u20139.","journal-title":"Biochem Soc Trans"},{"issue":"5","key":"634_CR56","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/jn\/138.5.914","volume":"138","author":"SV Konstantinova","year":"2008","unstructured":"Konstantinova SV et al. Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. J Nutr. 2008;138(5):914\u201320.","journal-title":"J Nutr"},{"issue":"8","key":"634_CR57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069454","volume":"8","author":"H Schartum-Hansen","year":"2013","unstructured":"Schartum-Hansen H et al. Assessment of urinary betaine as a marker of diabetes mellitus in cardiovascular patients. PLoS One. 2013;8(8), e69454.","journal-title":"PLoS One"},{"issue":"7","key":"634_CR58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021666","volume":"6","author":"M Lever","year":"2011","unstructured":"Lever M et al. Plasma lipids and betaine are related in an acute coronary syndrome cohort. PLoS One. 2011;6(7), e21666.","journal-title":"PLoS One"},{"issue":"2","key":"634_CR59","first-page":"78","volume":"7","author":"S Rajaie","year":"2011","unstructured":"Rajaie S, Esmaillzadeh A. Dietary choline and betaine intakes and risk of cardiovascular diseases: review of epidemiological evidence. ARYA Atheroscler. 2011;7(2):78\u201386.","journal-title":"ARYA Atheroscler"},{"issue":"1\u20132","key":"634_CR60","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cca.2007.05.001","volume":"383","author":"O Danne","year":"2007","unstructured":"Danne O et al. Whole blood choline and plasma choline in acute coronary syndromes: prognostic and pathophysiological implications. Clin Chim Acta. 2007;383(1\u20132):103\u20139.","journal-title":"Clin Chim Acta"},{"issue":"9","key":"634_CR61","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0002-9149(03)00149-8","volume":"91","author":"O Danne","year":"2003","unstructured":"Danne O et al. Prognostic implications of elevated whole blood choline levels in acute coronary syndromes. Am J Cardiol. 2003;91(9):1060\u20137.","journal-title":"Am J Cardiol"},{"issue":"5","key":"634_CR62","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjcard.2009.04.047","volume":"104","author":"RM LeLeiko","year":"2009","unstructured":"LeLeiko RM et al. Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome. Am J Cardiol. 2009;104(5):638\u201343.","journal-title":"Am J Cardiol"},{"key":"634_CR63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2261-7-20","volume":"7","author":"A Bidulescu","year":"2007","unstructured":"Bidulescu A et al. Usual choline and betaine dietary intake and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. BMC Cardiovasc Disord. 2007;7:20.","journal-title":"BMC Cardiovasc Disord"},{"key":"634_CR64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1475-2891-8-14","volume":"8","author":"A Bidulescu","year":"2009","unstructured":"Bidulescu A et al. Repeatability and measurement error in the assessment of choline and betaine dietary intake: the Atherosclerosis Risk in Communities (ARIC) study. Nutr J. 2009;8:14.","journal-title":"Nutr J"},{"issue":"33","key":"634_CR65","doi-asserted-by":"crossref","first-page":"12511","DOI":"10.1073\/pnas.0601056103","volume":"103","author":"ME Dumas","year":"2006","unstructured":"Dumas ME et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A. 2006;103(33):12511\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"634_CR66","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1196\/annals.1320.009","volume":"1033","author":"G Mingrone","year":"2004","unstructured":"Mingrone G. Carnitine in type 2 diabetes. Ann N Y Acad Sci. 2004;1033:99\u2013107.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"634_CR67","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0168-8227(91)90020-E","volume":"14","author":"B Capaldo","year":"1991","unstructured":"Capaldo B et al. Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients. Diabetes Res Clin Pract. 1991;14(3):191\u20135.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6 Pt 1","key":"634_CR68","first-page":"E946","volume":"255","author":"E Ferrannini","year":"1988","unstructured":"Ferrannini E et al. Interaction of carnitine with insulin-stimulated glucose metabolism in humans. Am J Physiol. 1988;255(6 Pt 1):E946\u201352.","journal-title":"Am J Physiol"},{"issue":"Suppl 1","key":"634_CR69","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/dmrr.987","volume":"25","author":"RL Mynatt","year":"2009","unstructured":"Mynatt RL. Carnitine and type 2 diabetes. Diabetes Metab Res Rev. 2009;25 Suppl 1:S45\u20139.","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"634_CR70","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0033-1333688","volume":"121","author":"A Vidal-Casariego","year":"2013","unstructured":"Vidal-Casariego A et al. Metabolic effects of L-carnitine on type 2 diabetes mellitus: systematic review and meta-analysis. Exp Clin Endocrinol Diabetes. 2013;121(4):234\u20138.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"634_CR71","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.mayocp.2013.02.007","volume":"88","author":"JJ DiNicolantonio","year":"2013","unstructured":"DiNicolantonio JJ et al. L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Mayo Clin Proc. 2013;88(6):544\u201351.","journal-title":"Mayo Clin Proc"},{"key":"634_CR72","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2261-14-88","volume":"14","author":"R Shang","year":"2014","unstructured":"Shang R, Sun Z, Li H. Effective dosing of L-carnitine in the secondary prevention of cardiovascular disease: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2014;14:88.","journal-title":"BMC Cardiovasc Disord"},{"issue":"52","key":"634_CR73","doi-asserted-by":"crossref","first-page":"21307","DOI":"10.1073\/pnas.1215689109","volume":"109","author":"S Craciun","year":"2012","unstructured":"Craciun S, Balskus EP. Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proc Natl Acad Sci U S A. 2012;109(52):21307\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"634_CR74","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1073\/pnas.1316569111","volume":"111","author":"Y Zhu","year":"2014","unstructured":"Zhu Y et al. Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. Proc Natl Acad Sci U S A. 2014;111(11):4268\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7285","key":"634_CR75","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin J et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59\u201365.","journal-title":"Nature"},{"issue":"7228","key":"634_CR76","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature07540","volume":"457","author":"PJ Turnbaugh","year":"2009","unstructured":"Turnbaugh PJ et al. A core gut microbiome in obese and lean twins. Nature. 2009;457(7228):480\u20134.","journal-title":"Nature"},{"issue":"12","key":"634_CR77","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.2337\/db10-0253","volume":"59","author":"JP Furet","year":"2010","unstructured":"Furet JP et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010;59(12):3049\u201357.","journal-title":"Diabetes"},{"issue":"8","key":"634_CR78","volume":"8","author":"X Zhang","year":"2013","unstructured":"Zhang X et al. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One. 2013;8(8), e71108.","journal-title":"PLoS One"},{"issue":"1","key":"634_CR79","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.gene.2013.11.081","volume":"537","author":"M Remely","year":"2014","unstructured":"Remely M et al. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene. 2014;537(1):85\u201392.","journal-title":"Gene"},{"issue":"11","key":"634_CR80","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/oby.2012.110","volume":"20","author":"CL Karlsson","year":"2012","unstructured":"Karlsson CL et al. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity (Silver Spring). 2012;20(11):2257\u201361.","journal-title":"Obesity (Silver Spring)"},{"issue":"11","key":"634_CR81","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.2337\/db11-0227","volume":"60","author":"A Everard","year":"2011","unstructured":"Everard A et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes. 2011;60(11):2775\u201386.","journal-title":"Diabetes"},{"issue":"22","key":"634_CR82","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","volume":"110","author":"A Everard","year":"2013","unstructured":"Everard A et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110(22):9066\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"634_CR83","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","volume":"63","author":"NR Shin","year":"2014","unstructured":"Shin NR et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut. 2014;63(5):727\u201335.","journal-title":"Gut"},{"issue":"2","key":"634_CR84","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/ismej.2010.118","volume":"5","author":"AW Walker","year":"2011","unstructured":"Walker AW et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 2011;5(2):220\u201330.","journal-title":"ISME J"},{"issue":"6052","key":"634_CR85","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1208344","volume":"334","author":"GD Wu","year":"2011","unstructured":"Wu GD et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334(6052):105\u20138.","journal-title":"Science"},{"issue":"7484","key":"634_CR86","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David LA et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559\u201363.","journal-title":"Nature"},{"issue":"7415","key":"634_CR87","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature11550","volume":"489","author":"CA Lozupone","year":"2012","unstructured":"Lozupone CA et al. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220\u201330.","journal-title":"Nature"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-015-0634-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-015-0634-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-015-0634-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T17:24:11Z","timestamp":1567013051000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-015-0634-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,25]]},"references-count":87,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["634"],"URL":"https:\/\/doi.org\/10.1007\/s11892-015-0634-1","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,25]]},"article-number":"63"}}